Farnesol misplaces tip-localized Rho proteins and inhibits cell wall integrity signalling in Aspergillus fumigatus.
Farnesol is known for inducing apoptosis in some fungi and mammalian cells. To evaluate its potential role as an antifungal agent, we studied its impact on the human pathogen Aspergillus fumigatus. We found that growth of A. fumigatus wild type is inhibited, but two cell wall mutants, Deltamnt1 andDeltaglfA, are much more susceptible to farnesol. This susceptibility is partially rescued by osmotic stabilization, suggesting that farnesol is a cell wall perturbing agent. However, farnesol does not activate but inhibit the cell wall integrity (CWI) pathway. Remarkably, mutants lacking AfMkk2 or AfMpkA, two kinases essential for CWI signalling, are also highly susceptible to farnesol, suggesting that its mode of action goes beyond inhibition of CWI signalling. Farnesyl derivatives are known for interfering with the function of prenylated proteins. We analysed the subcellular localization of two prenylated Rho family GTPases, AfRho1 and AfRho3, which are implicated in controlling CWI and the cytoskeleton. We found that under normal growth conditions AfRho1 and AfRho3 predominantly localize to the hyphal tip. After farnesol treatment this localization is rapidly lost, which is accompanied by swelling of the hyphal tips. Parallel displacement of tropomyosin from the tips suggests a concomitant disorganization of the apical actin cytoskeleton.
Dichtl
Karl
K
Max von Pettenkofer-Institut, Ludwig-Maximilians-Universität, Munich, Germany.
Ebel
Frank
F
Dirr
Franziska
F
Routier
Françoise H
FH
Heesemann
Jürgen
J
Wagener
Johannes
J
D001232:Aspergillus fumigatus / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D002473:Cell Wall / Q000187:drug effects / Q000378:metabolism; D003572:Cytochalasins / Q000494:pharmacology; D005204:Farnesol / Q000494:pharmacology*; D005656:Fungal Proteins / Q000235:genetics / Q000378:metabolism*; D005816:Genetic Complementation Test; D006801:Humans; D025301:Hyphae / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D018384:Oxidative Stress; D010641:Phenotype; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*; D020741:rho GTP-Binding Proteins / Q000235:genetics / Q000378:metabolism*
D003572:Cytochalasins; D005656:Fungal Proteins; D011993:Recombinant Fusion Proteins; C031218:cytochalasin A; D005204:Farnesol; D020741:rho GTP-Binding Proteins